Ethical Considerations in the Implantation of Neuromodulatory Devices.

Deep brain stimulation ethics neuromodulation neurostimulation responsive neurostimulation spinal cord stimulation

Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
02 2022
Historique:
received: 05 10 2020
revised: 26 11 2020
accepted: 21 12 2020
entrez: 7 2 2022
pubmed: 8 2 2022
medline: 9 2 2022
Statut: ppublish

Résumé

Neuromodulatory devices are increasingly used by neurosurgeons to manage a variety of chronic conditions. Given their potential benefits, it is imperative to create clear ethical guidelines for the use of these devices. We present a tiered ethical framework for neurosurgeon recommendations for the use of neuromodulatory devices. We conducted a literature review to identify factors neurosurgeons should consider when choosing to offer a neuromodulatory device to a patient. Neurosurgeons must weigh reductions in debilitating symptoms, improved functionality, and preserved quality of life against risks for intraoperative complications and adverse events due to stimulation or the device itself. Neurosurgeons must also evaluate whether patients and families will maintain responsibility for the management of neuromodulatory devices. Consideration of these factors should occur on an axis of resource allocation, ranging from provision of neuromodulatory devices to those with greatest potential benefit in resource-limited settings to provision of neuromodulatory devices to all patients with indications in contexts without resource limitations. Neurosurgeons must also take action to promote device effectiveness throughout the duration of care. Weighing risks and benefits of providing neuromodulatory devices and assessing ability to remain responsible for the devices on the level of the individual patient indicate which patients are most likely to achieve benefit from these devices. Consideration of these factors on an axis of resource allocation will allow for optimal provision of neuromodulatory devices to patients in settings of varied resources. Neurosurgeons play a primary role in promoting the effectiveness of these devices.

Identifiants

pubmed: 35125141
pii: S1094-7159(21)06975-0
doi: 10.1111/ner.13357
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

222-231

Informations de copyright

Copyright © 2021 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Nathan A Shlobin (NA)

Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: nathan.shlobin@northwestern.edu.

Joshua M Rosenow (JM)

Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH